SCHEMBL19383112

SCHEMBL19383112

Brc1ccc(-c2nc(-c3cccc(-c4ccccc4)c3)cc(-c3cccc(-c4ccccc4)c3)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.54
▸ MEN1 O00255 7/20 0.54
▸ KMT2A Q03164 7/20 0.54
▸ MAPT P10636 6/20 0.54
▸ HPGD P15428 5/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ LMNA P02545 2/20 0.54
▸ GLA P06280 1/20 0.54
▸ AGTR1 P30556 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ NTSR1 P30989 1/20 0.53
▸ NPC1 O15118 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ NFKB2 Q00653 1/20 0.53
▸ RELA Q04206 1/20 0.53
▸ MCL1 Q07820 2/20 0.50
▸ NR1H4 Q96RI1 1/20 0.50
▸ CYP1A1 P04798 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21808817 0.98 MEN1 (0.57) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL22913722 0.98 MEN1 (0.57) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL22534581 0.98 MEN1 (0.57) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL30400680 0.98 MEN1 (0.57) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL29714732 0.98 MEN1 (0.57) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL23197477 0.98 MEN1 (0.57) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL22914329 0.96 AGTR1 (0.58) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL15458583 0.96 AGTR1 (0.58) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL15887977 0.94 MEN1 (0.49) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL31190081 0.93 AGTR1 (0.58) ALDH1A1MEN1KMT2AMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11678576-B2 Heterocyclic compound and organic light emitting element comprising same LT MATERIALS CO., LTD. (KR) 2023-06-13 — — US disclosed
US-11678576-B2 Heterocyclic compound and organic light emitting element comprising same LT MATERIALS CO., LTD. (KR) 2023-06-13 — — US disclosed
US-20230013934-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-01-19 — — US disclosed
EP-3858831-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LT Materials Co., Ltd. (KR) 2021-08-04 — — EP disclosed
US-20210202863-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2021-07-01 — — US disclosed
US-20190106391-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2019-04-11 — — US disclosed
WO-2017157983-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2017-09-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210202863-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, CYP1A1 ALDH1A1 15/4885MEN1 351/4885KMT2A 592/4885
US-20190106391-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES TEC, NUDT1, DPYD ALDH1A1 326/4885MEN1 1683/4885KMT2A 3153/4885
US-20230013934-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CYP1B1, CYP1A1 ALDH1A1 6/4885MEN1 700/4885KMT2A 656/4885
US-11678576-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, CYP1A1 ALDH1A1 15/4885MEN1 351/4885KMT2A 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback